Antibodies News and Research

RSS
Researchers are in the race to beat Omicron

Researchers are in the race to beat Omicron

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

MU researchers identify highly prevalent mutations specific to Omicron variant

MU researchers identify highly prevalent mutations specific to Omicron variant

Many care home residents, staff tested positive for Covid-19 during the first two waves of the pandemic

Many care home residents, staff tested positive for Covid-19 during the first two waves of the pandemic

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

Vaccines alone are ineffective against the widely circulating Omicron variant

Vaccines alone are ineffective against the widely circulating Omicron variant

New opportunity to induce remission of peanut allergy in young children through oral immunotherapy

New opportunity to induce remission of peanut allergy in young children through oral immunotherapy

New COVID-19 vaccine promises vaccine equity because it has no patents

New COVID-19 vaccine promises vaccine equity because it has no patents

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

Nano-bubbles containing ACE2 protein can block infection from broad strains of SARS-CoV-2

Nano-bubbles containing ACE2 protein can block infection from broad strains of SARS-CoV-2

New study to help understand the effect of cancer medicine

New study to help understand the effect of cancer medicine

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

Research shows benefits of hybrid immunity to SARS-CoV-2

Research shows benefits of hybrid immunity to SARS-CoV-2

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

New cryo-EM method may be able to shortcut a big step in modern vaccine development

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination